
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Razan Alzeibak, Tatiana A. Mishchenko, Natalia Y. Shilyagina, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001926-e001926
Open Access | Times Cited: 389
Razan Alzeibak, Tatiana A. Mishchenko, Natalia Y. Shilyagina, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001926-e001926
Open Access | Times Cited: 389
Showing 1-25 of 389 citing articles:
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 365
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 365
Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status
Gürcan Günaydın, Mustafa Emre Gedik, Seylan Ayan
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 292
Gürcan Günaydın, Mustafa Emre Gedik, Seylan Ayan
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 292
Photodynamic Therapy: A Compendium of Latest Reviews
José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4447-4447
Open Access | Times Cited: 191
José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4447-4447
Open Access | Times Cited: 191
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Jin Zhang, Yandai Lin, Zhe Lin, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 188
Jin Zhang, Yandai Lin, Zhe Lin, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 188
Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy
Shenwu Zhang, Jing Wang, Zhiqiang Kong, et al.
Biomaterials (2022) Vol. 282, pp. 121433-121433
Closed Access | Times Cited: 175
Shenwu Zhang, Jing Wang, Zhiqiang Kong, et al.
Biomaterials (2022) Vol. 282, pp. 121433-121433
Closed Access | Times Cited: 175
Which cell death modality wins the contest for photodynamic therapy of cancer?
Tatiana A. Mishchenko, Irina V. Balalaeva, Anastasia A. Gorokhova, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 161
Tatiana A. Mishchenko, Irina V. Balalaeva, Anastasia A. Gorokhova, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 161
BODIPY as a Multifunctional Theranostic Reagent in Biomedicine: Self‐Assembly, Properties, and Applications
Hong‐Bo Cheng, Xiaoqiao Cao, Shuchun Zhang, et al.
Advanced Materials (2022) Vol. 35, Iss. 18
Closed Access | Times Cited: 139
Hong‐Bo Cheng, Xiaoqiao Cao, Shuchun Zhang, et al.
Advanced Materials (2022) Vol. 35, Iss. 18
Closed Access | Times Cited: 139
Light Technology for Efficient and Effective Photodynamic Therapy: A Critical Review
José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3484-3484
Open Access | Times Cited: 134
José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3484-3484
Open Access | Times Cited: 134
A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody
Zhilin Li, Hao Cai, Zhiqian Li, et al.
Bioactive Materials (2022) Vol. 21, pp. 299-312
Open Access | Times Cited: 120
Zhilin Li, Hao Cai, Zhiqian Li, et al.
Bioactive Materials (2022) Vol. 21, pp. 299-312
Open Access | Times Cited: 120
Functional states of myeloid cells in cancer
Lilian van Vlerken-Ysla, Yulia Y. Tyurina, Valerian E. Kagan, et al.
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 490-504
Open Access | Times Cited: 105
Lilian van Vlerken-Ysla, Yulia Y. Tyurina, Valerian E. Kagan, et al.
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 490-504
Open Access | Times Cited: 105
Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
Yunhao Wang, Qingfu Zhao, Binyu Zhao, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 98
Yunhao Wang, Qingfu Zhao, Binyu Zhao, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 98
ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines
Xu Liu, Yu Liu, Xiang Li, et al.
ACS Nano (2022) Vol. 16, Iss. 6, pp. 9240-9253
Closed Access | Times Cited: 92
Xu Liu, Yu Liu, Xiang Li, et al.
ACS Nano (2022) Vol. 16, Iss. 6, pp. 9240-9253
Closed Access | Times Cited: 92
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review
Cunqing Kong, Xingcai Chen
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6427-6446
Open Access | Times Cited: 87
Cunqing Kong, Xingcai Chen
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6427-6446
Open Access | Times Cited: 87
Triggered azobenzene-based prodrugs and drug delivery systems
Jundong Zhu, Tao Guo, Zheng Wang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 475-493
Closed Access | Times Cited: 83
Jundong Zhu, Tao Guo, Zheng Wang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 475-493
Closed Access | Times Cited: 83
Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
Nem Singh, Jungryun Kim, Jaewon Kim, et al.
Bioactive Materials (2022) Vol. 21, pp. 358-380
Open Access | Times Cited: 80
Nem Singh, Jungryun Kim, Jaewon Kim, et al.
Bioactive Materials (2022) Vol. 21, pp. 358-380
Open Access | Times Cited: 80
An Activatable Near‐Infrared Afterglow Theranostic Prodrug with Self‐Sustainable Magnification Effect of Immunogenic Cell Death
Zhiyuan Gao, Shaorui Jia, Hanlin Ou, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 40
Closed Access | Times Cited: 73
Zhiyuan Gao, Shaorui Jia, Hanlin Ou, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 40
Closed Access | Times Cited: 73
A mitochondria-localized iridium(iii ) photosensitizer for two-photon photodynamic immunotherapy against melanoma
Lili Wang, Johannes Karges, Fangmian Wei, et al.
Chemical Science (2023) Vol. 14, Iss. 6, pp. 1461-1471
Open Access | Times Cited: 65
Lili Wang, Johannes Karges, Fangmian Wei, et al.
Chemical Science (2023) Vol. 14, Iss. 6, pp. 1461-1471
Open Access | Times Cited: 65
Cell membrane biomimetic nanomedicines for cancer phototherapy
Min Chen, Yun Sun, Huiyu Liu
Deleted Journal (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 56
Min Chen, Yun Sun, Huiyu Liu
Deleted Journal (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 56
Photodynamic therapy combined with immunotherapy: Recent advances and future research directions
Marta Warszyńska, Paweł Repetowski, J. Dąbrowski
Coordination Chemistry Reviews (2023) Vol. 495, pp. 215350-215350
Open Access | Times Cited: 56
Marta Warszyńska, Paweł Repetowski, J. Dąbrowski
Coordination Chemistry Reviews (2023) Vol. 495, pp. 215350-215350
Open Access | Times Cited: 56
Innovative strategies for photodynamic therapy against hypoxic tumor
Xiaotong Li, Lei Chen, Miaoting Huang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 1, pp. 100775-100775
Open Access | Times Cited: 54
Xiaotong Li, Lei Chen, Miaoting Huang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 1, pp. 100775-100775
Open Access | Times Cited: 54
Photodynamic therapy in oral cancer: a review of clinical studies
Seyed Ali Mosaddad, Reza Abdollahi Namanloo, Seyedeh Sara Aghili, et al.
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 51
Seyed Ali Mosaddad, Reza Abdollahi Namanloo, Seyedeh Sara Aghili, et al.
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 51
A NIR‐II Fluorescent PolyBodipy Delivering Cationic Pt‐NHC with Type II Immunogenic Cell Death for Combined Chemotherapy and Photodynamic Immunotherapy
Bin Wang, Dongsheng Tang, Johannes Karges, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 29
Open Access | Times Cited: 47
Bin Wang, Dongsheng Tang, Johannes Karges, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 29
Open Access | Times Cited: 47
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 44
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 44
Targeting inflammation as cancer therapy
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death
Xu Liu, Yichao Lu, Xiang Li, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1058-1073
Closed Access | Times Cited: 20
Xu Liu, Yichao Lu, Xiang Li, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1058-1073
Closed Access | Times Cited: 20